Creatine kinase elevation after neuroleptic treatment

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Neuroleptic medications are commonly prescribed for psychiatric conditions.
• Elevated creatine kinase (CK) levels can indicate muscle damage or stress.
• Asymptomatic CK elevation is an uncommon but documented side effect of certain drugs.

Observation:

• Two patients presented with asymptomatic elevations in serum creatine kinase (CK) levels during oral neuroleptic therapy.
• No overt symptoms of muscle injury or neurological dysfunction were reported by either patient.
• One patient underwent a dechallenge and rechallenge protocol.

Findings:

• The patient who underwent rechallenge tolerated a different oral neuroleptic agent without recurrence of elevated CK levels.
• This suggests that the specific neuroleptic agent, rather than the class, may be implicated in CK elevation.
• The underlying mechanisms for neuroleptic-induced asymptomatic CK elevation remain unclear.

Implications:

• Clinicians should be aware of the potential for asymptomatic CK elevation with oral neuroleptics.
• Monitoring CK levels may be warranted in patients on specific neuroleptic agents.
• Further research is needed to elucidate the pathophysiology and clinical significance of this finding.